Selumetinib

Selumetinib ATC Code L01EE04 : Antineoplastic and immunomodulating agents - Antineoplastic drugs - Protein kinase inhibitors - Mitogen-activated protein kinase (MEK) inhibitors - Selumetinib
Selumetinib
RoutesOral
FDA Approval Date2020-04-10
Molecular FormulaC17H15BrClFN4O3
Molecular Weight457.68 g/mol
CAS Number606143-52-6
Brand namesKoselugo


ATC Codes

  1. Alimentary tract and metabolisma
  2. Blood and blood forming organs
  3. Cardiovascular system
  4. Dermatological drugs
  5. Genitourinary system and reproductive hormones
  6. Systemic hormonal preparations
  7. Antiinfectives for systemic use
  8. Antineoplastic and immunomodulating agents
  9. Musculoskeletal system
  10. Nervous system
  11. Antiparasitic products, insecticides and repellents
  12. Respiratory system
  13. Sensory organs
  14. Various ATC structures

The newly added categories

  1. Givosiran
  2. Volanesorsen
  3. Casimersen
  4. Zanubrutinib
  5. Tivozanib
  6. Fedratinib
  7. Tucatinib
  8. Everolimus
  9. Abemaciclib
  10. Selumetinib